Medicenna Therapeutics Corp.

RENAISSANCE TECHNOLOGIES LLC MDNAF

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

85,113

Value ($000)

Weight

0.0%

2020 Q3 - 2023 Q3 (13 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	25	0.0%	85,113	9/30/2023
2023 Q2	8/11/2023	44	0.0%	90,400	6/30/2023
2023 Q1	5/12/2023	95	0.0%	150,300	3/31/2023
2022 Q4	2/13/2023	81	0.0%	176,542	12/31/2022
2022 Q3	11/14/2022	38	0.0%	45,400	9/30/2022
2022 Q2	8/12/2022	37	0.0%	32,100	6/30/2022
2022 Q1	5/13/2022	51	0.0%	39,700	3/31/2022
2021 Q4	2/11/2022	161	0.0%	99,000	12/31/2021
2021 Q3	11/12/2021	33	0.0%	11,900	9/30/2021
2021 Q2	8/13/2021	98	0.0%	32,446	6/30/2021
2021 Q1	5/13/2021	574	0.0%	141,200	3/31/2021
2020 Q4	2/10/2021	608	0.0%	130,500	12/31/2020
2020 Q3	11/13/2020	945	0.0%	229,900	9/30/2020